Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Axcella Health Inc. (AXLA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events ... |
| 08/18/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 08/18/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/07/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 08/04/2023 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Interactive Data |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 06/29/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previous... |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 03/30/2023 |
8-K
| Quarterly results |
| 02/24/2023 |
4
| Koziel Margaret (Chief Medical Officer) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 70,000 options to buy
@ $0.6759, valued at
$47.3k
|
|
| 02/24/2023 |
4
| Hinshaw William (President & CEO) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.6759, valued at
$185.9k
|
|
| 02/24/2023 |
4
| Fehlner Paul (SVP & Chief Legal Officer) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 70,000 options to buy
@ $0.6759, valued at
$47.3k
|
|
| 02/14/2023 |
SC 13G/A
| HarbourVest Partners L.P. reports a 8.4% stake in Axcella Health Inc. |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 15% stake in AXCELLA HEALTH INC |
| 12/15/2022 |
8-K
| Quarterly results |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/01/2022 |
8-K
| Quarterly results |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 2,743,902 shares
@ $1.64, valued at
$4.5M
Bought 2,757,333 shares
@ $1.64, valued at
$4.5M
Bought 914,634 shares
@ $1.64, valued at
$1.5M
Bought 919,111 shares
@ $1.64, valued at
$1.5M
Bought 3,048,780 shares
@ $1.64, valued at
$5M
|
|
| 10/17/2022 |
SC 13D/A
| Flagship VentureLabs IV, LLC reports a 39.8% stake in AXCELLA HEALTH INC. |
| 10/17/2022 |
3
| Flagship Pioneering Inc. (10% Owner) has filed a Form 3 on Axcella Health Inc. |
| 10/17/2022 |
3
| Rosiello Robert L. (Director) has filed a Form 3 on Axcella Health Inc. |
| 10/17/2022 |
3
| NISSEN TORBEN STRAIGHT (Director) has filed a Form 3 on Axcella Health Inc. |
| 10/17/2022 |
4
| Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 3,658,536 shares
@ $1.64, valued at
$6M
|
|
| 10/13/2022 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...|
Docs:
|
"Letter re: Securities Registered under Registration Statement on Form S-3",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of October 13, 2022, between Axcella Health Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser a..." |
|
| 10/13/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 09/29/2022 |
8-K
| Quarterly results |
| 09/23/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 09/23/2022 |
SC 13D/A
| Flagship VentureLabs IV, LLC reports a 35.8% stake in AXCELLA HEALTH INC. |
|
|
|